ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Ginkgo Bioworks Holdings Inc

Ginkgo Bioworks Holdings Inc (DNA)

10.08
1.34
(15.33%)
Closed December 21 4:00PM
10.06
-0.02
(-0.20%)
After Hours: 7:29PM

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
10.06
Bid
-
Ask
-
Volume
3,321,449
8.40 Day's Range 10.5335
5.26 52 Week Range 75.20
Market Cap
Previous Close
8.74
Open
8.46
Last Trade
50
@
10.0601
Last Trade Time
Financial Volume
$ 33,248,130
VWAP
10.0101
Average Volume (3m)
1,138,720
Shares Outstanding
57,478,905
Dividend Yield
-
PE Ratio
-0.65
Earnings Per Share (EPS)
-15.53
Revenue
251.46M
Net Profit
-892.87M

About Ginkgo Bioworks Holdings Inc

Ginkgo Bioworks Holdings Inc is building a platform to enable customers to program cells as easily to program computers. The company's platform is market agnostic and enables biotechnology applications across diverse markets, from food and agriculture to industrial chemicals to pharmaceuticals. Ginkgo Bioworks Holdings Inc is building a platform to enable customers to program cells as easily to program computers. The company's platform is market agnostic and enables biotechnology applications across diverse markets, from food and agriculture to industrial chemicals to pharmaceuticals.

Sector
Biological Pds,ex Diagnstics
Industry
Blank Checks
Headquarters
Wilmington, Delaware, USA
Founded
2021
Ginkgo Bioworks Holdings Inc is listed in the Biological Pds,ex Diagnstics sector of the New York Stock Exchange with ticker DNA. The last closing price for Ginkgo Bioworks was $8.74. Over the last year, Ginkgo Bioworks shares have traded in a share price range of $ 5.26 to $ 75.20.

Ginkgo Bioworks currently has 57,478,905 shares outstanding. The market capitalization of Ginkgo Bioworks is $502.37 million. Ginkgo Bioworks has a price to earnings ratio (PE ratio) of -0.65.

DNA Latest News

Ginkgo Bioworks Awarded $9.4 Million in Partnership with Carnegie Mellon University to Develop Implantable Cell-Based Bioelectronic Devices for Disease Treatment Under ARPA-H's REACT Program

Ginkgo Bioworks Awarded $9.4 Million in Partnership with Carnegie Mellon University to Develop Implantable Cell-Based Bioelectronic Devices for Disease Treatment Under ARPA-H's REACT Program PR...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.27-2.613746369810.3310.488.4714877609.19065881CS
43.4251.50602409646.6411.986.513636179.70248835CS
122.227.9898218837.8611.986.0111387208.53987878CS
26-6.58-39.543269230816.6418.45.261977119612.44087158CS
52-61.94-86.02777777787275.25.262614107129.06075367CS
156-423.14-97.6777469991433.24625.262292558672.01755628CS
260-439.54-97.762455516449.6634.565.262184117685.08521039CS

DNA - Frequently Asked Questions (FAQ)

What is the current Ginkgo Bioworks share price?
The current share price of Ginkgo Bioworks is $ 10.06
How many Ginkgo Bioworks shares are in issue?
Ginkgo Bioworks has 57,478,905 shares in issue
What is the market cap of Ginkgo Bioworks?
The market capitalisation of Ginkgo Bioworks is USD 502.37M
What is the 1 year trading range for Ginkgo Bioworks share price?
Ginkgo Bioworks has traded in the range of $ 5.26 to $ 75.20 during the past year
What is the PE ratio of Ginkgo Bioworks?
The price to earnings ratio of Ginkgo Bioworks is -0.65
What is the cash to sales ratio of Ginkgo Bioworks?
The cash to sales ratio of Ginkgo Bioworks is 2.31
What is the reporting currency for Ginkgo Bioworks?
Ginkgo Bioworks reports financial results in USD
What is the latest annual turnover for Ginkgo Bioworks?
The latest annual turnover of Ginkgo Bioworks is USD 251.46M
What is the latest annual profit for Ginkgo Bioworks?
The latest annual profit of Ginkgo Bioworks is USD -892.87M
What is the registered address of Ginkgo Bioworks?
The registered address for Ginkgo Bioworks is CORPORATION TRUST CENTER, 1209 ORANGE ST, WILMINGTON, DELAWARE, 19801
What is the Ginkgo Bioworks website address?
The website address for Ginkgo Bioworks is www.ginkgobioworks.com
Which industry sector does Ginkgo Bioworks operate in?
Ginkgo Bioworks operates in the BLANK CHECKS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
VNCEVince Holding Corp
$ 4.70
(69.06%)
1.06M
SRFMSurf Air Mobility Inc
$ 3.33
(23.79%)
376.77k
BBBlackBerry Limited
$ 3.685
(23.66%)
40.8M
ALURAllurion Technologies Inc
$ 0.3439
(22.87%)
744.34k
CLWClearWater Paper Corporation
$ 30.26
(22.46%)
3.5M
IIPRInnovative Industrial Properties Inc
$ 73.50
(-22.91%)
3.15M
KUKEKuke Music Holding Limited
$ 0.31
(-20.51%)
61.48k
NVONovo Nordisk
$ 85.00
(-17.83%)
53.81M
CANGCango Inc
$ 5.08
(-11.81%)
2.44M
BNEDBarnes and Noble Education Inc
$ 9.965
(-10.31%)
1.55M
QBTSD Wave Quantum Inc
$ 6.638
(4.21%)
124.23M
PFEPfizer Inc
$ 26.36
(2.29%)
111.08M
APOApollo Global Management Inc
$ 171.03
(0.83%)
94.47M
TAT&T Inc
$ 22.75
(0.80%)
88.77M
FFord Motor Company
$ 9.885
(1.49%)
87.61M

DNA Discussion

View Posts
Monksdream Monksdream 14 hours ago
DNA, 10 day hourly
👍️ 1
PonkenPlonken PonkenPlonken 16 hours ago
cheap
πŸ‘οΈ0
Monksdream Monksdream 2 months ago
DNA under $10
πŸ‘οΈ0
Monksdream Monksdream 3 months ago
DNA 10 day hourly post reverse split
πŸ‘οΈ0
hwang_jini hwang_jini 3 months ago
Cascade (Gates) top holder
πŸ‘οΈ0
Monksdream Monksdream 3 months ago
DNA new. 52 w eek low
πŸ‘οΈ0
Monksdream Monksdream 4 months ago
DNA new 52/week low
πŸ‘οΈ0
Monksdream Monksdream 4 months ago
DNA new 52 week low
πŸ‘οΈ0
Monksdream Monksdream 4 months ago
DNA new 52 week low
πŸ‘οΈ0
ItsMyOption ItsMyOption 4 months ago
even after 1:40 R/S DNA still has too many shares outstanding and corporate insiders have poorly mismanaged the company.
Ginkgo Bioworks needs complete restructure and less corporate greed. Some of their founders sell shares daily as they where gifted too many.
I stopped buying long ago and waiting to see if management can get their act together - they all deserve a pay cut!
👍️ 1
Monksdream Monksdream 4 months ago
DNA new 52 low
πŸ‘οΈ0
Dingbatt Dingbatt 4 months ago
Interesting stock bought a few for tracking
To see what the crawdads do
πŸ‘οΈ0
ItsMyOption ItsMyOption 4 months ago
poor management as they falsely pumped this stock now passing R/S effective Aug. 20
They also know they committed fraud and had to pass = 2. Officer Exculpation Proposal

Item 2 was to approve Article VIII of the Company’s Amended and Restated Certificate of Incorporation to permit officer exculpation (the β€œOfficer Exculpation Proposal”), designated to be voted upon by the holders of Class A common stock and Class B common stock, voting together as a single class. The results of the vote were as follows:

exculpation
noun
a defense of some offensive behavior or some failure to keep a promise etc.
his transparent self-justification was unacceptable
the act of freeing from guilt or blame
πŸ‘οΈ0
hwang_jini hwang_jini 5 months ago
bio scam….

https://www.prnewswire.com/news-releases/ginkgo-bioworks-to-hold-special-meeting-of-shareholders-302210173.html
πŸ‘οΈ0
Acme Investments Acme Investments 6 months ago
Sometimes I wonder if big names get kickbacks in exchange for their names being used??
πŸ‘οΈ0
Acme Investments Acme Investments 6 months ago
Cathy led her sheep 🐑 to slaughter!! Worst performing IPO I've ever seen!!
👍️ 1
Acme Investments Acme Investments 6 months ago
😂😂😂😂😂😂😂
πŸ‘οΈ0
trade2brich trade2brich 6 months ago
ARK dumped all holdings. I am out. Cut my losses.
πŸ‘οΈ0
Monksdream Monksdream 6 months ago
It will reverse split because there is no choice
πŸ‘οΈ0
JohnnyBlaze JohnnyBlaze 6 months ago
Average down or cut losses?
πŸ‘οΈ0
Monksdream Monksdream 6 months ago
DNA new 52 week low
πŸ‘οΈ0
Acme Investments Acme Investments 6 months ago
Timber!!
πŸ‘οΈ0
JohnnyBlaze JohnnyBlaze 6 months ago
Bought a few
πŸ‘οΈ0
Acme Investments Acme Investments 6 months ago
R/S will be announced without warning!! Proceed with caution!!
👍️ 1
ItsMyOption ItsMyOption 6 months ago
Yes, new low and very unhappy with DNA management. They were too slow to start restructuring and they still have one of the founders selling stock daily - what does he know?
πŸ‘οΈ0
Monksdream Monksdream 6 months ago
DNA new 52 week low
πŸ‘οΈ0
Stump Jumper Stump Jumper 7 months ago
I appreciate the response and opinion. I would like to think we would get a small bounce upward from here before a possible RS....
πŸ‘οΈ0
philaya philaya 7 months ago
Got in low...
Bounce ready.
πŸ‘οΈ0
ItsMyOption ItsMyOption 7 months ago
I feel we are close to bottom possible around.50 as lots of shorts took this down fast. We know DNA is in restructuring mode, which they should have done a long time ago. We still have one of their founders selling shares daily which should be in their ethic guidance as he most likely has inside info on R/S soon.

Long term I am positive but unhappy with management.
πŸ‘οΈ0
Stump Jumper Stump Jumper 7 months ago
Is this the bottom?
πŸ‘οΈ0
Acme Investments Acme Investments 7 months ago
Acknowledge Me!! Lol 😂
πŸ‘οΈ0
wiredawg wiredawg 7 months ago
Yep, yet another SPAC born public company that's in the toilet, I fore see a reverse announcement coming very soon, given they've received a listing standard Notice form the NYSE...
πŸ‘οΈ0
Monksdream Monksdream 7 months ago
DNA new 52 week low
πŸ‘οΈ0
Acme Investments Acme Investments 7 months ago
I'll take that as a no!! Lol 😂 The Cathy curse continues!!
πŸ‘οΈ0
Acme Investments Acme Investments 7 months ago
Still happy??
πŸ‘οΈ0
ItsMyOption ItsMyOption 7 months ago
Why DNA will keep going down is all the insider selling from page 43 of last finacials: Austin has been selling shares daily so it is founders driving the price below SEC requirements of min of $1.00
Ginkgo’s Founders currently own nearly 20% of the outstanding shares of Ginkgo, the vast majority of which are in Class B shares
? Class B shares are not freely tradable (must be converted to Class A) and are often not shown on automated data services
? As such, these aggregation services (such as Bloomberg or Yahoo) can be unhelpful in determining actual holdings of certain investors, including
our Founders, who may hold different classes of shares which may not be included

Founder sales through April 29, 2024 relative to total holdings(1)
Mandatory Sell-to-Cover(2) 10b5-1 plan
Shares sold
(in millions) % of holdings
Shares sold
(in millions) % of holdings
Jason (CEO) 12.3 11.3% 10.4 9.6%
Reshma (COO) 12.3 11.4% 1.9 1.8%
Barry (CTO) 12.3 11.2% 1.9 1.7%
Austin 12.3 11.3% 0.9 0.8
πŸ‘οΈ0
Acme Investments Acme Investments 7 months ago
Hope you took profits!! They just wanted to burn the shorts!!
πŸ‘οΈ0
Acme Investments Acme Investments 7 months ago
That's a lot of risk for 30%......Eventually you'll get snake eyes!!
πŸ‘οΈ0
trade2brich trade2brich 7 months ago
Bought at .70….up 30%
πŸ‘οΈ0
Acme Investments Acme Investments 7 months ago
Don't know if you noticed but Cathy has lost her MOJO and her investors a lot of money!! Proceed with caution ⚠!!
πŸ‘οΈ0
trade2brich trade2brich 7 months ago
ARK bought 12 million shares on Friday
πŸ‘οΈ0
Acme Investments Acme Investments 7 months ago
Ark is like the cattle whisperer!! Slaughter awaits!!
πŸ‘οΈ0
Monksdream Monksdream 8 months ago
DNA new 52 week low
πŸ‘οΈ0
Monksdream Monksdream 8 months ago
Aren’t you the smart one

πŸ‘οΈ0
trade2brich trade2brich 8 months ago
I did not I keep buying
πŸ‘οΈ0
Monksdream Monksdream 8 months ago
No, you buy
New 52 week lo
πŸ‘οΈ0
trade2brich trade2brich 8 months ago
Buy
πŸ‘οΈ0
Monksdream Monksdream 8 months ago
DNA new 52 lo

πŸ‘οΈ0
hwang_jini hwang_jini 8 months ago
https://www.rand.org/pubs/articles/2024/artificial-intelligence-and-biotechnology-risks-and.html
πŸ‘οΈ0
Monksdream Monksdream 8 months ago
DNA new 52 lo
πŸ‘οΈ0

Your Recent History

Delayed Upgrade Clock